Clinical Trials Browser

Neomycin × Clear all

NCT04729322 2025-12-23

Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT02682485 2023-04-26

SES-DTA

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

NCT03856671 2023-04-05

Prophylatic Effect Preoperative Antibiotics With Mechanical Bowel Preparation in SSIs

Phase NA Completed

Gastrointestinal

Postoperative Complications, Surgical Wound Infection, Colorectal Neoplasms

NCT03042091 2018-08-22

Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery

Phase EARLY_PHASE1 Unknown

Gastrointestinal

Diverticulitis, Surgical Wound Infection, Colorectal Neoplasms, Inflammatory Bowel Diseases

NCT02001909 2015-08-13

Effect of Neomycin on the Pharmacokinetics of Regorafenib

Phase 1 Completed

Neoplasms